Allogene stock price today
Web2 days ago · SOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in four upcoming investor conferences. Canaccord … Web2 days ago · SOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company …
Allogene stock price today
Did you know?
WebThe Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts. Investor Relations Allogene Therapeutics Skip to main navigation Contact Us Careers SHARE About Us At A Glance Management Team Board of Directors Scientific Advisors WebApr 8, 2024 · In a report released on April 6, Luca Issi from RBC Capital maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report), with a price target of $15.00. The company’s shares ...
WebApr 6, 2024 · Allogene Therapeutics (ALLO) Stock Price & Analysis 826 Followers Portfolio ALLO Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range …
WebMar 30, 2024 · A month has gone by since the last earnings report for Allogene Therapeutics (ALLO Quick Quote ALLO - Free Report) .Shares have lost about 19.4% in that time frame, underperforming the S&P 500. WebApr 11, 2024 · ALLO Allogene Therapeutics, Inc.Stock Price & Overview. $5.11 0.19 ( +3.86%) 4:00 PM 03/29/23. NASDAQ $USD Post-Market: $5.14 +0.03 (+0.59%) 7:54 …
WebMar 31, 2024 · ALLO News Today Why did Allogene Therapeutics stock go down today? S&P 500 4,109.31 DOW 33,274.15 [BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad) Bear market expert makes new prediction (Ad) [BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad) Bear market expert makes new …
WebAllogene Therapeutics Inc Follow Share $4.89 After Hours: $4.89 (0.00%) 0.00 Closed: Apr 6, 4:56:21 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Beyond Meat … boston\u0027s only #1 hitWebApr 13, 2024 · Allogene Therapeutics Inc. (NASDAQ:ALLO) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -1.29% to the previous day’s close … boston\\u0027s original nameWebApr 13, 2024 · Financially as well, Allogene could use some work. For instance, its Altman Z-Score sits at 0.1 below breakeven, reflecting a distressed enterprise at risk of … boston\u0027s peace of mindWebApr 12, 2024 · The average twelve-month price prediction for Allogene Therapeutics is $17.69 with a high price target of $31.00 and a low price target of $6.00. Do Wall Street analysts like Allogene Therapeutics more than its competitors? Analysts like Allogene Therapeutics less than other Medical companies. boston\\u0027s oldest hotelWebAllogene Therapeutics Inc () Stock Market info Recommendations: Buy or sell Allogene Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Allogene Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Allogene Therapeutics's ALLO shares and potentially … boston\u0027s phone numberWebJan 11, 2024 · You can see the complete list of today’s Zacks #1 Rank stocks here. Alkermes’ earnings per share estimates for 2024 have increased from $0.70 to $0.71 in the past 30 days. Shares of Alkermes have... boston\\u0027s phone numberWeb1 day ago · Here are some big stocks recording gains in today’s session. ... initiated coverage on the stock with a Buy rating and a $29 price ... with a Buy rating and a $15 … boston\\u0027s peace of mind